Friday, June 25, 2021 Daily Archives

Catalent bolsters CGT biz with RheinCell Therapeutics buy

by

The acquisition of RheinCell Therapeutics will position Catalent as a partner of choice across the iPSC value chain, says the CDMO. The deal, financial details of which have not been divulged, sees contract development manufacturing organization (CDMO) Catalent buy developer and manufacturer of induced pluripotent stem cells (iPSCs) RheinCell Therapeutics. The deal is expected to close before the end of this year and will enable Catalent to offer the foundations to scale iPSC-based therapies. iPSCs cells can be separated into…

June 25, 2021

AbCellera responds to future pandemic threat with $190m+ Canadian facility

by

AbCellera will build a manufacturing facility in Vancouver, Canada to prepare for future pandemics and advance their own clinical pipeline. The 130,000 square-foot Vancouver facility will produce therapeutic antibodies making it the first of its kind in Canada. The facility will not be used to support any COVID-19 related products. However, in-country manufacturing of antibodies is “important for Canada because it fills a major gap in our ability as a nation to respond to future pandemics,†Murray McCutcheon, vice president,…

June 25, 2021